In a strategic maneuver poised to transform the landscape of medtech, Doccla, a rising star in the health technology domain, has achieved a significant feat. The acquisition of the medically certified cloud-based platform OpenTeleHealth (OTH) propels Doccla into the global spotlight, endowing the UK-based virtual ward provider with an immediate and pervasive international presence. While the financial intricacies of this pivotal deal remain undisclosed, the ramifications are set to reverberate throughout the industry.
A young contender in the medtech realm, Doccla commenced its journey in 2019 with a distinctive mission—to empower patients through at-home health monitoring, effectively curbing hospital visits, and fostering wellness within the comfort of one's abode. With a commitment to tailor digital monitoring systems to individual patient needs, Doccla’s arsenal captures crucial vitals such as heart rate, respiration rate, body temperature, blood oxygen levels, and blood pressure.
The culmination of a collaborative journey, the union between Doccla and OTH is a testament to their symbiotic relationship, cultivated over an extended period. The seamless integration of the OTH workforce into Doccla's fold marks a pivotal turning point, accelerating progress to the ultimate advantage of patient outcomes across Europe and beyond.
Founded in 2019 as a research endeavor in partnership with the British NHS, Doccla has evolved into an influential force, etching its presence in one of three UK healthcare systems and extending its reach to 10 European markets.
